Precision-targeted Transcranial Magnetic Stimulation in the Treatment of Primary Dystonia

Status

UNKNOWN

Phases

Early Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04727177

Enrollment

Registered

2021-01-27

Start date

2020-11-01

Completion date

2021-05-01

Last updated

2021-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Dystonia, Transcranial Magnetic Stimulation

Brief summary

In this scheme, TMS treatment of Primary dystonia is planned by precise magnetic resonance positioning.

Interventions

DEVICETranscranial magnetic stimulation

Transcranial magnetic stimulation (TMS) is a noninvasive biological stimulation technique born in the middle of 1980's.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

MALE

Healthy volunteers

Inclusion criteria

* Primary dystonia

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame	Description
Burke-Fahn-Marsden dystonia rating scale	Five days	The BFMMS measures dystonia in nine body regions (including the eyes, mouth, speech and swallowing, neck, trunk, arms, and legs) with scores ranging from 0 (minimum) to 120 (maximum).The higher scores mean a worse outcome. The BFMDS is a functional marker consisting of parental- or self-reported daily activities (involving speech, handwriting,feeding, eating, swallowing, hygiene, dressing, and walking),with scores ranging from 0 (completely independent) to 30 (completely dependent).

Countries

China

Contacts

Primary ContactJianhua Feng

380028654@qq.com89713749

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026